Evaluation of the vitamin A on the treatment of Brucellosis.
Phase 3
Recruiting
- Conditions
- Brucellosis.Brucellosis
- Registration Number
- IRCT20180815040807N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
All patients who have positive serologic tests for Brucella.
Exclusion Criteria
All patients with focal complications of Brucellosis include Brucella spondylitis, Brucella endocarditis, and Neurobuccosis.
All patients who have any immune deficiency.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse. Timepoint: Before the intervention, 1, 3, 6, 12 and 15 months after the intervention. Method of measurement: Patients will be evaluated for the disease recurrence by measuring antibody titres against brucellosis.
- Secondary Outcome Measures
Name Time Method